Showing results (71-80 of 117) with videos related to
Sort By:
Pageof 12
World Journal of Urology|March 31, 2015
The use of hemostatic agents does not prevent hemorrhagic complications of robotic partial nephrectomyBenoit Peyronnet, Emmanuel Oger, Zineddine Khene, et al.Iscience|February 9, 2026
BCG immunotherapy for bladder cancer triggers systemic and local BCG-specific CD4<sup>+</sup> Th1 responsesPaul Rollin, Benjamin Pluskwa, Emilie Artru, et al.European Urology Oncology|April 16, 2025
Challenges in Defining Clinical Complete Response to Systemic Therapy in Muscle-invasive Bladder Cancer: Insights from the EORTC STARBURST ProjectAlexandra Masson-Lecomte, Guillaume Grisay, Julien Van Damme, et al.European Urology Oncology|November 19, 2024
Anatomic Factors Associated with Complications After Radical Prostatectomy: A Systematic Review and Meta-analysisArthur Peyrottes, Charles Dariane, Michael Baboudjian, et al.Cancers|November 11, 2022
Oncological Outcomes of Distal Ureterectomy for High-Risk Urothelial Carcinoma: A Multicenter Study by The French Bladder Cancer CommitteeAlexandra Masson-Lecomte, Victoire Vaillant, Mathieu Roumiguié, et al.Urologia Internationalis|April 6, 2017
Off-Clamp versus On-Clamp Robotic Partial Nephrectomy: A Multicenter Match-Paired Case-Control StudyBenoit Peyronnet, Zine-Eddine Khene, Benjamin Pradère, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 14, 2025
Safety and Efficacy of Neoadjuvant Durvalumab Plus Gemcitabine/Cisplatin or Carboplatin in Patients With Operable High-Risk Upper Tract Urothelial Carcinoma: The iNDUCT-GETUG V08 TrialNadine Houédé, Thierry Chevallier, François Audenet, et al.European Urology Oncology|June 24, 2026
Evaluating the Surrogacy of Pathological Complete Response at Radical Cystectomy in Neoadjuvant-based Muscle-invasive Bladder Cancer TrialsPietro Scilipoti, Aleksander Ślusarczyk, Constance Thibault, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 20, 2016
Inflammatory-Related Genetic Variants in Non-Muscle-Invasive Bladder Cancer Prognosis: A Multimarker Bayesian AssessmentAlexandra Masson-Lecomte, Evangelina López de Maturana, Michael E Goddard, et al.European Urology|September 13, 2021
European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (Ta, T1, and Carcinoma in Situ)Marko Babjuk, Maximilian Burger, Otakar Capoun, et al.Pageof 12